-
mechanisms in patients with rare or undefined hemostatic disorders. We will tackle this at the system-wide level using PRM-based targeted proteomics, DIA-based global plasma profiling and proteogenomic-based
-
spectrometry-based proteomics in the area of benign hematology. We are a vibrant, international group of 35-40 colleagues (consisting of group leaders, postdocs, PhD students and technicians) that study the
-
many functional neutrophil assays available will be combined in this project with plasma proteomics to elucidate the possible key factors involved. The ultimate goal is to find means to inhibit NET
Searches related to proteomics
Enter an email to receive alerts for proteomics positions